Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)
Clinical trial NCT01531998 · COMPLETED
Trial details
- NCT number
- NCT01531998
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.